Qvar 50 inhaler

국가: 영국

언어: 영어

출처: MHRA (Medicines & Healthcare Products Regulatory Agency)

유효 성분:

Beclometasone dipropionate

제공처:

Teva UK Ltd

ATC 코드:

R03BA01

INN (국제 이름):

Beclometasone dipropionate

복용량:

50microgram/1dose

약제 형태:

Pressurised inhalation

관리 경로:

Inhalation

수업:

No Controlled Drug Status

처방전 유형:

Caution - AMP level prescribing advised

제품 요약:

BNF: 03020000; GTIN: 5023497172611

환자 정보 전단

PACKAGE LEAFLET: INFORMATION FOR THE USER
QVAR
®
50 & 100 AEROSOL
BECLOMETASONE DIPROPIONATE
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as yours.

If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Qvar Aerosol is and what it is used for
2.
What you need to know before you use Qvar Aerosol
3.
How to use Qvar Aerosol
4.
Possible side effects
5.
How to store Qvar Aerosol
6.
Contents of pack and other information
1.
WHAT QVAR AEROSOL IS AND WHAT IT IS USED FOR
Qvar Aerosol contains beclometasone dipropionate, which is one of a
group of medicines known as
corticosteroids.
Qvar Aerosol is used to prevent the symptoms of mild, moderate, or
severe asthma, in patients who require
regular treatment.
HOW YOUR MEDICINE WORKS

Qvar Aerosol works deep in your lungs to make breathing easier by
reducing the inflammation, swelling
and irritation in the airways. This type of medicine is known as a
‘preventer’. It needs to be taken
regularly every day, even if you have no symptoms.

This inhaler will not give immediate relief of wheezing or
breathlessness during a sudden asthma attack.
You will need to use a ‘reliever’ inhaler, which contains a
different medicine. You should still continue
to use this inhaler.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE QVAR AEROSOL
DO NOT USE QVAR AEROSOL IF YOU:

are allergic to beclometasone dipropionate or any of the other
ingredients of this medicine (listed in
section 6)

are allergic to other similar inhalers.

are suffering from a sudden attack of breathlessness. It will not
help. Use a quick-a

제품 특성 요약

OBJECT 1
QVAR MDI 50 MICROGRAMS
Summary of Product Characteristics Updated 19-Oct-2017 | Teva UK
Limited
1. Name of the medicinal product
Qvar 50 Aerosol 50 micrograms per actuation pressurised inhalation
solution
2. Qualitative and quantitative composition
Beclometasone Dipropionate 50 micrograms per metered (ex-valve) dose.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Pressurised inhalation, solution.
A colourless solution in a pressurised aluminium canister fitted with
a metering valve and an actuator.
Qvar contains a propellant, which does not contain any
chlorofluorocarbons (CFCs).
4. Clinical particulars
4.1 Therapeutic indications
Prophylactic management of mild, moderate or severe asthma.
4.2 Posology and method of administration
Posology
Qvar is for inhalation use only.
Patients should be instructed in the proper use of their inhaler,
including rinsing out their mouth with
water after use.
NOTE: THE RECOMMENDED TOTAL DAILY DOSE OF QVAR IS LOWER THAN THAT FOR
CURRENT BECLOMETASONE
DIPROPIONATE CONTAINING PRODUCTS AND SHOULD BE ADJUSTED TO THE NEEDS
OF THE INDIVIDUAL PATIENT.
ADULT STARTING AND MAINTENANCE DOSE:
It is important to gain control of asthma symptoms and optimise
pulmonary function as soon as possible.
When patients' symptoms remain under satisfactory control, the dose
should be titrated to the lowest dose
at which effective control of asthma is maintained.
To be effective, inhaled Qvar must be used on a regular basis even
when patients are asymptomatic.
THERAPY IN NEW PATIENTS SHOULD BE INITIATED AT THE FOLLOWING
Mild asthma:
100 to 200 micrograms per day in two divided doses.
Moderate asthma:
200 to 400 micrograms per day in two divided doses.
Severe asthma:
400 to 800 micrograms per day in two divided doses.
Patients on budesonide inhalers may be transferred to Qvar as
described below
The general approach to switching patients to Qvar involves two steps
as detailed below. Specific
guidance on switching well-controlled and poorly-controlled
(symptomatic) patients i